Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

Furin inhibitors as potential therapeutics for treating COVID-19 and other diseases, wherein furin is integral for their pathogenicity and progression.

29 Mar 2022

A bioinformatics approach for detecting SARS-CoV-2 co-infections

Researchers discuss a novel bioinformatics-based method for the detection of SARS-CoV-2 co-infections with the Delta and Omicron variants.

29 Mar 2022

The different actions of CBD in SARS-CoV-2 infection

An article has described the role of cannabidiol as a potential inhibitor of hyperinflammation in SARS-CoV-2 infection.

29 Mar 2022

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

A new study assessed the molecular dynamics of potentially active natural phytochemicals to target the SARS-CoV-2 main protease.

29 Mar 2022

Investigating SARS-CoV-2 detection using Raman microscopy

Researchers investigated the specific intracellular signature of SARS-CoV-2 infection using Raman microscopy.

29 Mar 2022

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

A recent viewpoint illustrated that evaluating T cell responses to COVID-19 is essential to inform public health initiatives.

29 Mar 2022

Study investigates SARS-CoV-2 infection in Swiss stray cats

Recently, researchers surveyed the prevalence of SARS-CoV-2 infection in Swiss stray cats.

29 Mar 2022

Characterization of the different expressed RNAseq variants in SARS-CoV-2 infected patients

A recent study analyzed the RNAseq variants of COVID-19 patients and healthy donors.

29 Mar 2022

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

A new study evaluated the waning efficacy of the COVID-19 ChAdOx1 and BNT162b2 vaccines over six months following the second dose.

29 Mar 2022

Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

Researchers tracked the rapid shift from the new SARS-CoV-2 VOC Omicron BA.1 sub-variant dominance to BA.2 sub-variant dominance in Sweden between January and March 2022.

29 Mar 2022

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Researchers evaluated the cellular and humoral immunity following heterologous and homologous COVID-19 immunization regimens for up to five months.

29 Mar 2022

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

In a new study, researchers tested the bi-, tri-, and tetravalent formulations of Newcastle disease virus (NDV)-based low-cost vaccine in mice.

29 Mar 2022

Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City

Researchers evaluated the association between new IBD diagnoses in NYC and the COVID-19 pandemic.

29 Mar 2022

The relationship between circadian misalignment and the risk of COVID-19 infection

An interesting new study links changes in the daily rhythms of the human body with the risk of COVID-19.

29 Mar 2022

SCENTinel 1.1 found to rapidly screen SARS-CoV-2-linked olfactory disorders

...

29 Mar 2022

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

A recent paper examines the occurrence of other respiratory viral infections during this period in patients already infected with SARS-CoV-2.

29 Mar 2022

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

A new study presented the findings of the Phase 3 trial of the Nanocovax coronavirus disease 2019 (COVID-19) vaccine.

29 Mar 2022

Algal metabolites as novel drugs against viruses

A new review article published in the Journal of Biotechnology has provided information on various nutraceutical metabolites extracted from algae.

29 Mar 2022

Is SARS-CoV-2 a Superantigen?

Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), scientists have been conducting extensive studies to understand various aspects of the virus. Researchers have stated that SARS-CoV-2 manifests several biological and clinical consequences of a superantigen

29 Mar 2022

Is COVID-19 vaccination during pregnancy safe?

A new retrospective cohort study conducted across a large population of pregnant women in Ontario, Canada, has confirmed that the coronavirus disease 2019 (COVID-19) vaccination administered during pregnancy is not associated with any increased risk of adverse maternal or neonatal peripartum outcomes.

29 Mar 2022

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Furin inhibitors as potential therapies to combat SARS-CoV-2 and other diseases

A bioinformatics approach for detecting SARS-CoV-2 co-infections

The different actions of CBD in SARS-CoV-2 infection

Study shows potential inhibition of SARS-CoV-2 main protease by natural phytochemicals

Investigating SARS-CoV-2 detection using Raman microscopy

Viewpoint explains how T cell testing can help research on population-level SARS-CoV-2 adaptive immunity and inform public health policies

Study investigates SARS-CoV-2 infection in Swiss stray cats

Characterization of the different expressed RNAseq variants in SARS-CoV-2 infected patients

Study explores the waning efficacy of SARS-CoV-2 ChAdOx1 and BNT162b2 vaccines

Study tracks the rapid shift from Omicron BA.1 to BA.2 sub-variant dominance in Sweden

Immune response dynamics following COVID-19 heterologous and homologous vaccinations

Newcastle disease virus-based trivalent vaccine found to be effective across SARS-CoV-2 variants in mice

Association between the COVID-19 pandemic and inflammatory bowel disease presentation in New York City

The relationship between circadian misalignment and the risk of COVID-19 infection

SCENTinel 1.1 found to rapidly screen SARS-CoV-2-linked olfactory disorders

Clinical outcomes of SARS-CoV-2 coinfection with influenza viruses, respiratory syncytial virus, or adenoviruses

Results of Phase 3 Nanocovax SARS-CoV-2 vaccine trial suggest robust effectiveness

Algal metabolites as novel drugs against viruses

Is SARS-CoV-2 a Superantigen?

Is COVID-19 vaccination during pregnancy safe?

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in